Literature DB >> 23544203

The Detection of Motion by Blind Subjects With the Epiretinal 60-Electrode (Argus II) Retinal Prosthesis.

Jessy D Dorn1, Ashish K Ahuja, Avi Caspi, Lyndon da Cruz, Gislin Dagnelie, Jose-Alain Sahel, Robert J Greenberg, Matthew J McMahon.   

Abstract

OBJECTIVE: To investigate the ability of 28 blind subjects implanted with a 60-electrode Argus II (Second Sight Medical Products Inc) retinal prosthesis system to detect the direction of a moving object.
METHODS: Blind subjects (bare light perception or worse in both eyes) with retinitis pigmentosa were implanted with the Argus II prosthesis as part of a phase 1/2 feasibility study at multiple clinical sites worldwide. The experiment measured their ability to detect the direction of motion of a high-contrast moving bar on a flatscreen monitor in 3 conditions: with the prosthesis system on and a 1-to-1 mapping of spatial information, with the system off, and with the system on but with randomly scrambled spatial information.
RESULTS: Fifteen subjects (54%) were able to perform the task significantly better with their prosthesis system than they were with their residual vision, 2 subjects had significantly better performance with their residual vision, and no difference was found for 11 subjects. Of the 15 better-performing subjects, 11 were available for follow-up testing, and 10 of them had significantly better performance with normal rather than with scrambled spatial information.
CONCLUSIONS: This work demonstrates that blind subjects implanted with the Argus II retinal prosthesis were able to perform a motion detection task they could not do with their native vision, confirming that electrical stimulation of the retina provides spatial information from synchronized activation of multiple electrodes. TRIAL REGISTRATION: clinicaltrials.gov Identifier:NCT00407602

Entities:  

Mesh:

Year:  2013        PMID: 23544203      PMCID: PMC3924899          DOI: 10.1001/2013.jamaophthalmol.221

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  12 in total

1.  Retinal prosthesis: an encouraging first decade with major challenges ahead.

Authors:  J F Rizzo; J Wyatt; M Humayun; E de Juan; W Liu; A Chow; R Eckmiller; E Zrenner; T Yagi; G Abrams
Journal:  Ophthalmology       Date:  2001-01       Impact factor: 12.079

2.  Morphometric analysis of macular photoreceptors and ganglion cells in retinas with retinitis pigmentosa.

Authors:  J L Stone; W E Barlow; M S Humayun; E de Juan; A H Milam
Journal:  Arch Ophthalmol       Date:  1992-11

3.  Visual performance using a retinal prosthesis in three subjects with retinitis pigmentosa.

Authors:  Douglas Yanai; James D Weiland; Manjunatha Mahadevappa; Robert J Greenberg; Ione Fine; Mark S Humayun
Journal:  Am J Ophthalmol       Date:  2007-03-23       Impact factor: 5.258

4.  Implantation and explantation of a wireless epiretinal retina implant device: observations during the EPIRET3 prospective clinical trial.

Authors:  Gernot Roessler; Thomas Laube; Claudia Brockmann; Thomas Kirschkamp; Babac Mazinani; Michael Goertz; Christian Koch; Ingo Krisch; Bernd Sellhaus; Hoc Khiem Trieu; Joachim Weis; Norbert Bornfeld; Harald Röthgen; Arthur Messner; Wilfried Mokwa; Peter Walter
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05-06       Impact factor: 4.799

5.  Feasibility study of a retinal prosthesis: spatial vision with a 16-electrode implant.

Authors:  Avi Caspi; Jessy D Dorn; Kelly H McClure; Mark S Humayun; Robert J Greenberg; Matthew J McMahon
Journal:  Arch Ophthalmol       Date:  2009-04

6.  Interim results from the international trial of Second Sight's visual prosthesis.

Authors:  Mark S Humayun; Jessy D Dorn; Lyndon da Cruz; Gislin Dagnelie; José-Alain Sahel; Paulo E Stanga; Artur V Cideciyan; Jacque L Duncan; Dean Eliott; Eugene Filley; Allen C Ho; Arturo Santos; Avinoam B Safran; Aries Arditi; Lucian V Del Priore; Robert J Greenberg
Journal:  Ophthalmology       Date:  2012-01-11       Impact factor: 12.079

7.  Can subretinal microphotodiodes successfully replace degenerated photoreceptors?

Authors:  E Zrenner; A Stett; S Weiss; R B Aramant; E Guenther; K Kohler; K D Miliczek; M J Seiler; H Haemmerle
Journal:  Vision Res       Date:  1999-07       Impact factor: 1.886

8.  Extraocular surgery for implantation of an active subretinal visual prosthesis with external connections: feasibility and outcome in seven patients.

Authors:  D Besch; H Sachs; P Szurman; D Gülicher; R Wilke; S Reinert; E Zrenner; K U Bartz-Schmidt; F Gekeler
Journal:  Br J Ophthalmol       Date:  2008-07-28       Impact factor: 4.638

9.  Psychophysical assessment of low visual function in patients with retinal degenerative diseases (RDDs) with the Diagnosys full-field stimulus threshold (D-FST).

Authors:  M Klein; D G Birch
Journal:  Doc Ophthalmol       Date:  2009-11-03       Impact factor: 2.379

10.  Visual perception elicited by electrical stimulation of retina in blind humans.

Authors:  M S Humayun; E de Juan; G Dagnelie; R J Greenberg; R H Propst; D H Phillips
Journal:  Arch Ophthalmol       Date:  1996-01
View more
  53 in total

Review 1.  Learning to see again: biological constraints on cortical plasticity and the implications for sight restoration technologies.

Authors:  Michael Beyeler; Ariel Rokem; Geoffrey M Boynton; Ione Fine
Journal:  J Neural Eng       Date:  2017-06-14       Impact factor: 5.379

2.  Changes in ganglion cell physiology during retinal degeneration influence excitability by prosthetic electrodes.

Authors:  Alice Cho; Charles Ratliff; Alapakkam Sampath; James Weiland
Journal:  J Neural Eng       Date:  2016-02-23       Impact factor: 5.379

3.  The use of Argus® II retinal prosthesis by blind subjects to achieve localisation and prehension of objects in 3-dimensional space.

Authors:  Yvonne Hsu-Lin Luo; Joe Jianjiang Zhong; Lyndon da Cruz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-12-31       Impact factor: 3.117

Review 4.  Persistent remodeling and neurodegeneration in late-stage retinal degeneration.

Authors:  Rebecca L Pfeiffer; Robert E Marc; Bryan William Jones
Journal:  Prog Retin Eye Res       Date:  2019-07-26       Impact factor: 21.198

Review 5.  Brain Machine Interfaces for Vision Restoration: The Current State of Cortical Visual Prosthetics.

Authors:  Soroush Niketeghad; Nader Pouratian
Journal:  Neurotherapeutics       Date:  2019-01       Impact factor: 7.620

6.  Acquisition of Visual Perception in Blind Adults Using the BrainPort Artificial Vision Device.

Authors:  Amy C Nau; Christine Pintar; Aimee Arnoldussen; Christopher Fisher
Journal:  Am J Occup Ther       Date:  2015 Jan-Feb

7.  Effects of subtenon-injected autologous platelet-rich plasma on visual functions in eyes with retinitis pigmentosa: preliminary clinical results.

Authors:  Umut Arslan; Emin Özmert; Sibel Demirel; Firdevs Örnek; Figen Şermet
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-03-15       Impact factor: 3.117

Review 8.  Retinal Prosthesis System for Advanced Retinitis Pigmentosa: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2016-06-01

9.  Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial.

Authors:  Lyndon da Cruz; Jessy D Dorn; Mark S Humayun; Gislin Dagnelie; James Handa; Pierre-Olivier Barale; José-Alain Sahel; Paulo E Stanga; Farhad Hafezi; Avinoam B Safran; Joel Salzmann; Arturo Santos; David Birch; Rand Spencer; Artur V Cideciyan; Eugene de Juan; Jacque L Duncan; Dean Eliott; Amani Fawzi; Lisa C Olmos de Koo; Allen C Ho; Gary Brown; Julia Haller; Carl Regillo; Lucian V Del Priore; Aries Arditi; Robert J Greenberg
Journal:  Ophthalmology       Date:  2016-07-21       Impact factor: 12.079

10.  Retinal Degeneration Reduces Consistency of Network-Mediated Responses Arising in Ganglion Cells to Electric Stimulation.

Authors:  Young Jun Yoon; Jae-Ik Lee; Ye Ji Jang; Seungki An; Jae Hun Kim; Shelley I Fried; Maesoon Im
Journal:  IEEE Trans Neural Syst Rehabil Eng       Date:  2020-06-18       Impact factor: 3.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.